Biotricity (OTCMKTS:BTCY) Stock Price Down 17.7% – Here’s Why

Biotricity Inc. (OTCMKTS:BTCY)’s stock price dropped 17.7% during mid-day trading on Friday . The stock traded as low as $0.2250 and last traded at $0.2750. Approximately 551,486 shares traded hands during trading, an increase of 840% from the average daily volume of 58,644 shares. The stock had previously closed at $0.3343.

Biotricity Price Performance

The firm has a market cap of $7.69 million, a price-to-earnings ratio of -1.62 and a beta of 1.33. The firm has a fifty day simple moving average of $0.48 and a two-hundred day simple moving average of $0.50.

Biotricity (OTCMKTS:BTCY) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.05. The company had revenue of $3.89 million for the quarter, compared to analyst estimates of $3.90 million. Equities analysts anticipate that Biotricity Inc. will post -1.43 earnings per share for the current fiscal year.

Biotricity Company Profile

Biotricity (OTCMKTS:BTCY) is a medical device and digital health company specializing in remote cardiovascular monitoring and chronic disease management. The company’s flagship offering, the Bioflux system, integrates a wearable ECG patch with a cloud-based analytics platform to deliver real-time heart rhythm data and diagnostic insights. By combining wireless biosensors, mobile applications, and secure data transmission, Biotricity aims to simplify patient monitoring for healthcare providers and enhance early detection of arrhythmias and other cardiac events.

In addition to its core ambulatory ECG solution, Biotricity provides a suite of digital health products designed for broader chronic care management.